Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for Alzheimer Disease Compared With Medicare Beneficiaries With Alzheimer Disease and Mild Cognitive Impairment.
Anderson TS, Ayanian JZ, Souza J, Landon BE.. Asian Nurs Res (Korean Soc Nurs Sci). 2020 Dec;14(5):293-299. doi: 10.1016/j.anr.2020.09.001. Epub 2020 Sep 10. Asian Nurs Res (Korean Soc Nurs Sci). 2020. PMID: 32920173.
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
